Published in Rinsho Byori on February 01, 1985
Sleep patterns and total mortality: a 12-year follow-up study in Japan. J Epidemiol (2000) 2.49
Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost (2006) 2.40
Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. J Biol Chem (1976) 2.07
Infantile acute subdural hematoma. Clinical analysis of 26 cases. J Neurosurg (1984) 1.96
Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. J Clin Invest (1978) 1.79
The transcondylar approach to extradural nonneoplastic lesions of the craniovertebral junction. J Neurosurg (1996) 1.74
A test of significance for geographic clusters of disease. Int J Epidemiol (1979) 1.68
Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest (1980) 1.58
Mediation of cardioprotection by transforming growth factor-beta. Science (1990) 1.52
Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J Biol Chem (1994) 1.50
Type 1 plasminogen activator inhibitor. Prog Hemost Thromb (1989) 1.49
Acute effects of cigarette smoking on platelet-dependent thrombin generation. Eur Heart J (2001) 1.49
Cardiac metastasis of lung cancer. A study of metastatic pathways and clinical manifestations. Cancer (1992) 1.44
Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency. J Clin Invest (1979) 1.43
A novel vascular relaxing agent, N-(6--aminohexyl)-5-chloro-1-naphthalensulfonamide which affects vascular smooth muscle actomyosin. J Pharmacol Exp Ther (1978) 1.42
Communicating triventricular hydrocephalus and its treatment with a lumboperitoneal shunt. Neurosurgery (1985) 1.37
Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Krüppel-like zinc-finger protein. Blood (1994) 1.36
Antithrombin 3 depression and thrombin generation acceleration in women taking oral contraceptives. Am J Obstet Gynecol (1971) 1.34
The behavior of alpha2-plasmin inhibitor in fibrinolytic states. J Clin Invest (1977) 1.31
Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation (1990) 1.31
Lactation-dependent expression of an mRNA splice variant with an exon for a multiply O-glycosylated domain of mouse milk fat globule glycoprotein MFG-E8. Biochem Biophys Res Commun (1999) 1.27
Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor. J Biol Chem (1994) 1.25
Plasma thrombomodulin in health and diseases. Blood (1990) 1.24
Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. J Clin Invest (1982) 1.22
Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas. J Virol (1987) 1.21
Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor. Blood (1987) 1.20
Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo. Blood (1994) 1.20
Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. Jpn J Cancer Res (1999) 1.17
Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. J Thromb Haemost (2006) 1.17
Chronic encapsulated intracerebellar hematoma in infancy: case report. Neurosurgery (1984) 1.17
Recognition DNA sequence of a novel putative transcription factor, BCL6. Biochem Biophys Res Commun (1994) 1.16
Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood (1994) 1.16
Studies on suppressor cell function in thyroid diseases. J Clin Endocrinol Metab (1979) 1.16
Pancreatic cancer with metastasis to the larynx. J Laryngol Otol (1980) 1.16
The wide distribution of endornaviruses, large double-stranded RNA replicons with plasmid-like properties. Arch Virol (2005) 1.15
Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma. J Med Virol (1990) 1.15
Carboxy-terminal cytoplasmic domain of mouse butyrophilin specifically associates with a 150-kDa protein of mammary epithelial cells and milk fat globule membrane. Biochim Biophys Acta (1995) 1.15
Inhibition of aromatase activity by green tea extract catechins and their endocrinological effects of oral administration in rats. Food Chem Toxicol (2002) 1.14
Detection of JC virus in the brains of aged patients without progressive multifocal leukoencephalopathy by the polymerase chain reaction and Southern hybridization analysis. Neurosci Lett (1992) 1.13
Critical role of calcium- dependent epidermal growth factor receptor transactivation in PC12 cell membrane depolarization and bradykinin signaling. J Biol Chem (1997) 1.11
Regulation of STAT3-mediated signaling by LMW-DSP2. Oncogene (2006) 1.09
The alpha2-plasmin inhibitor levels in liver diseases. Clin Chim Acta (1978) 1.09
Characterization of the promoter region of the human c-kit proto-oncogene. Jpn J Cancer Res (1993) 1.08
Antisense expression of a rice sucrose transporter OsSUT1 in rice (Oryza sativa L.). Plant Cell Physiol (2001) 1.08
Distribution of cold-insoluble globulin in plasma and tissues. Ann N Y Acad Sci (1978) 1.07
Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction. Am Heart J (2000) 1.07
Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol (1997) 1.06
Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin. Thromb Haemost (1978) 1.06
JC virus infection in allograft kidneys: analysis by polymerase chain reaction and immunohistochemistry. Transplantation (2001) 1.06
Sensitive spectrophotometric method for the determination of ethylenediaminetetraacetic acid in foods. Analyst (1993) 1.05
Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr (2007) 1.05
Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. J Antimicrob Chemother (2007) 1.05
A 33-kDa allergen from rice (Oryza sativa L. Japonica). cDNA cloning, expression, and identification as a novel glyoxalase I. J Biol Chem (2001) 1.04
Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol (1994) 1.04
Inhibitory spectrum of alpha 2-plasmin inhibitor. Proc Natl Acad Sci U S A (1979) 1.03
Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1. Clin Endocrinol (Oxf) (2000) 1.03
Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor. J Biol Chem (1982) 1.02
Mucoepidermoid carcinoma of the thymic region. Acta Pathol Jpn (1982) 1.01
Increase of T cells in Graves' disease. Lancet (1973) 1.01
The effect of K + on the membrane potential in HeLa cells. Biochim Biophys Acta (1973) 1.01
Air in acute epidural hematomas. Report of two cases. J Neurosurg (1986) 1.00
Inhibitors of the fibrinolytic enzyme system. Semin Thromb Hemost (1984) 1.00
DUSP22/LMW-DSP2 regulates estrogen receptor-alpha-mediated signaling through dephosphorylation of Ser-118. Oncogene (2007) 0.99
Bilateral chronic subdural hematomas associated with intracranial hypotension--case report. Neurol Med Chir (Tokyo) (1996) 0.99
The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator. J Cell Biol (1990) 0.98
The extraction of vascular plasminogen activator from human cadavers and a description of some of its properties. Am J Clin Pathol (1971) 0.98
Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock. Proc Soc Exp Biol Med (1988) 0.97
Cross-linking of alpha 2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor. Biochim Biophys Acta (1981) 0.97
Expanding intracerebellar hematoma: a possible clinicopathological entity. Neurosurgery (1986) 0.97
A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. Arterioscler Thromb Vasc Biol (1997) 0.96
Natural inhibitors of fibrinolysis. Prog Cardiovasc Dis (1979) 0.96
Congenital alpha(2)-plasmin inhibitor deficiencies: a review. Br J Haematol (2001) 0.96
Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias. Blood (1994) 0.95
Factor XI gene (F11) is located on the distal end of the long arm of human chromosome 4. Cytogenet Cell Genet (1989) 0.95
Inhibition of platelet aggregation by protease inhibitors. Possible involvement of proteases in platelet aggregation. Blood (1978) 0.94
A thrombotic state due to an abnormal protein C. N Engl J Med (1988) 0.94
Human serum plasminogen antiactivator: its distinction from antiplasmin. Am J Physiol (1971) 0.94
Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor. J Biol Chem (1986) 0.94
Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin. FEBS Lett (1983) 0.94
Study on anti-androgenic effects of bisphenol a diglycidyl ether (BADGE), bisphenol F diglycidyl ether (BFDGE) and their derivatives using cells stably transfected with human androgen receptor, AR-EcoScreen. Food Chem Toxicol (2004) 0.94
Dissimilarity of human vascular plasminogen activator and human urokinase. J Lab Clin Med (1971) 0.94
Molecular analysis of a novel protein kinase in maturing rice seed. Gene (1998) 0.94
Retracted Molecular cloning and characterization of a novel dual specificity phosphatase, LMW-DSP2, that lacks the cdc25 homology domain. J Biol Chem (2001) 0.94
Assay of alpha2-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate. Thromb Res (1978) 0.93
Percutaneous transfemoral spring coil embolization of a pseudoaneurysm of the femoral artery. Cathet Cardiovasc Diagn (1992) 0.93
EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy. Br J Cancer (2013) 0.93
Decisions at hand: a decision support system on handhelds. Stud Health Technol Inform (2001) 0.93
Anti-malarial activity of leaf-extract of hydrangea macrophylla, a common Japanese plant. Acta Med Okayama (2000) 0.92
Fibrinolytic states in a patient with congenital deficiency of alpha 2-plasmin inhibitor. Blood (1980) 0.92
Venous infarction following the interhemispheric approach in patients with acute subarachnoid hemorrhage. J Neurosurg (1991) 0.92
Acute toxic encephalopathy with symmetrical low density areas in the thalami and the cerebellum. Childs Nerv Syst (1985) 0.92
Platelet-dependent thrombin generation in patients with hyperlipidemia. J Am Coll Cardiol (1997) 0.92
A xylem sap retrieval pathway in rice leaf blades: evidence of a role for endocytosis? J Exp Bot (2008) 0.92
Inhibition of proteases in coagulation, kinin-forming and complement systems by alpha2-plasmin inhibitor. J Biochem (1977) 0.91
Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation (1997) 0.91
Plasma thrombomodulin as a marker of vascular injuries in collagen vascular diseases. Am J Clin Pathol (1994) 0.91
Effect of protein C and activated protein C on coagulation and fibrinolysis in normal human subjects. Thromb Haemost (1990) 0.91
Feature mining and predictive model construction from severe trauma patient's data. Int J Med Inform (2001) 0.91